Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
by Saiag, Philippe (Author)
, Gutzmer, R. (Author)
, Ascierto, P. A. (Author)
, Maio, M. (Author)
, Grob, J. -J. (Author)
, Murawa, P. (Author)
, Dreno, B. (Author)
, Ross, M. (Author)
, Weber, J. (Author)
, Hauschild, A. (Author)
, Rutkowski, P. (Author)
, Testori, A. (Author)
, Levchenko, E. (Author)
, Enk, Alexander (Author)
, Misery, L. (Author)
, Vanden Abeele, C. (Author)
, Vojtek, I. (Author)
, Peeters, O. (Author)
, Brichard, V. G. (Author)
, Therasse, P. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource